Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Conditions: Hepatocellular Carcinoma Interventions: Drug: TKI+Cardunilimab Sponsors: Peking Union Medical College Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research